Literature DB >> 22031620

Long-term therapy with thalidomide in hereditary hemorrhagic telangiectasia: case report and literature review.

Chih-Hsuan Chen1, Hsao-Hsun Hsu, Rey-Heng Hu, Po-Huang Lee, Cheng-Maw Ho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22031620     DOI： 10.1177/0091270011417824

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  5 in total

Review 1.  Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide.

Authors:  Massimo Franchini; Francesco Frattini; Silvia Crestani; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

Review 2.  Gastrointestinal Bleeding Following LVAD Placement from Top to Bottom.

Authors:  Kelly Cushing; Vladimir Kushnir
Journal:  Dig Dis Sci       Date:  2016-03-26       Impact factor: 3.199

Review 3.  Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.

Authors:  Wanqiu Chen; Eun-Jung Choi; Cameron M McDougall; Hua Su
Journal:  Transl Stroke Res       Date:  2014-04-12       Impact factor: 6.829

Review 4.  Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.

Authors:  Daniela S Ardelean; Michelle Letarte
Journal:  Front Genet       Date:  2015-02-11       Impact factor: 4.599

5.  Thalidomide Effects in Patients with Hereditary Hemorrhagic Telangiectasia During Therapeutic Treatment and in Fli-EGFP Transgenic Zebrafish Model.

Authors:  Hong-Ling Peng; Yi-Fang Yi; Shun-Ke Zhou; Si-Si Xie; Guang-Sen Zhang
Journal:  Chin Med J (Engl)       Date:  2015-11-20       Impact factor: 2.628
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.